Biomarck Pharmaceuticals

Bismarck Pharmaceuticals, Ltd. is a clinical-stage biotechnology company focused on treating patients with inflammatory and immunological diseases, using our platform of patent-protected peptides that have been developed to inhibit MARCKS.